Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estrogen and Fear Extinction Network
NCT02673606Phase 1Completed
- Sponsor
- NYU Langone Health
- Start
- Jan 2013
- Primary completion
- Apr 2019
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of estradiol in phobic disorder (3 arms), sponsored by NYU Langone Health. Primary endpoint: Impact of exogenous administration of estradiol on the neural correlates of fear extinction at 3 days. Started Jan 2013; status: completed.
02
Drugs
estradiol
03
Conditions
phobic disorder
Beyond the preview
Go deeper on NCT02673606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02673606.